硕世生物
(688399)
| 流通市值：34.30亿 | | | 总市值：34.30亿 |
| 流通股本：1.24亿 | | | 总股本：1.24亿 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 345,770,457.64 | 477,403,569.11 | 483,772,564.12 | 294,693,999.69 |
| 交易性金融资产 | 1,367,445,956.1 | 1,213,542,795.53 | 1,096,525,482.4 | 1,358,537,596.58 |
| 应收票据及应收账款 | 40,436,194.75 | 40,340,273.45 | 39,460,080.68 | 50,786,882.26 |
| 其中：应收票据 | 187,555.2 | 220,182.84 | 48,060 | 40,128 |
| 应收账款 | 40,248,639.55 | 40,120,090.61 | 39,412,020.68 | 50,746,754.26 |
| 应收款项融资 | 1,004,054.17 | 858,163.5 | 383,850 | 500,016.88 |
| 预付款项 | 16,485,472.92 | 11,804,657.71 | 12,000,651.94 | 24,186,758.54 |
| 其他应收款合计 | 6,043,614.89 | 6,730,954.59 | 6,421,818.58 | 4,978,963.35 |
| 存货 | 47,092,713.12 | 41,636,863.48 | 51,502,275.41 | 53,153,428.7 |
| 其他流动资产 | 3,276,534.18 | 2,888,017.4 | 4,851,732.13 | 2,481,706.05 |
| 流动资产合计 | 1,827,554,997.77 | 1,795,205,294.77 | 1,694,918,455.26 | 1,789,319,352.05 |
| 非流动资产: | | | | |
| 长期股权投资 | 298,101,973.23 | 299,790,133.96 | 301,393,623.42 | 314,822,178.9 |
| 其他权益工具投资 | 12,287,416.95 | 12,287,416.95 | 12,287,416.95 | 4,138,483.28 |
| 其他非流动金融资产 | 239,443,549.58 | 241,186,668.14 | 233,586,480.63 | 230,091,118.01 |
| 固定资产 | 499,359,190.66 | 508,993,326.24 | 518,049,063.36 | 531,236,434.37 |
| 在建工程 | 150,632,624.89 | 112,740,044.78 | 94,921,971.39 | 63,178,300.8 |
| 使用权资产 | 9,747,174.33 | 11,206,990.52 | 12,758,513.95 | 9,527,541.89 |
| 无形资产 | 24,942,416.43 | 25,489,351.87 | 26,044,453.97 | 25,740,302.13 |
| 长期待摊费用 | 4,193,434.97 | 5,037,120.31 | 6,116,230.6 | 22,068,106.27 |
| 递延所得税资产 | 57,640,510.16 | 59,242,031.56 | 64,782,840.27 | 71,040,232.05 |
| 其他非流动资产 | 597,388,033.7 | 593,027,758.87 | 589,491,991.88 | 587,470,650.41 |
| 非流动资产合计 | 1,893,736,324.9 | 1,869,000,843.2 | 1,859,432,586.42 | 1,859,313,348.11 |
| 资产总计 | 3,721,291,322.67 | 3,664,206,137.97 | 3,554,351,041.68 | 3,648,632,700.16 |
| 流动负债: | | | | |
| 短期借款 | 463,171,055.35 | 440,640,479.86 | 316,741,560.48 | 414,453,559.95 |
| 应付票据及应付账款 | 73,344,775.53 | 31,913,230.24 | 60,500,345.51 | 32,759,510.75 |
| 应付账款 | 73,344,775.53 | 31,913,230.24 | 60,500,345.51 | 32,759,510.75 |
| 合同负债 | 14,360,483.5 | 17,651,265.07 | 17,404,407.95 | 19,820,900.29 |
| 应付职工薪酬 | 11,150,408.91 | 13,183,269.25 | 19,552,361.32 | 16,872,928.54 |
| 应交税费 | 2,321,173.88 | 3,081,296.68 | 2,885,537.77 | 3,346,575.9 |
| 其他应付款合计 | 23,968,061.41 | 27,279,835.01 | 43,838,524.8 | 45,326,691.8 |
| 一年内到期的非流动负债 | 4,093,946.07 | 4,501,800.3 | 4,729,347.94 | 4,133,599.23 |
| 其他流动负债 | 1,802,451.18 | 1,651,932.35 | 1,923,434.28 | 2,558,942.38 |
| 流动负债合计 | 594,212,355.83 | 539,903,108.76 | 467,575,520.05 | 539,272,708.84 |
| 非流动负债: | | | | |
| 长期借款 | 81,124,713.8 | 70,872,654.74 | 48,679,197.76 | 32,000,000 |
| 租赁负债 | 5,436,224.47 | 6,165,363.5 | 6,937,222.36 | 4,343,099.91 |
| 长期应付职工薪酬 | 50,000,000 | 50,000,000 | 50,000,000 | 50,000,000 |
| 递延收益 | 46,854,610.24 | 49,815,031.42 | 52,522,315.46 | 55,425,912.91 |
| 递延所得税负债 | 123.47 | 388.47 | 666.9 | - |
| 非流动负债合计 | 183,415,671.98 | 176,853,438.13 | 158,139,402.48 | 141,769,012.82 |
| 负债合计 | 777,628,027.81 | 716,756,546.89 | 625,714,922.53 | 681,041,721.66 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 83,871,721 | 83,871,721 | 83,871,721 | 83,871,721 |
| 资本公积 | 633,884,069.77 | 633,884,069.77 | 633,884,069.77 | 633,884,069.77 |
| 其他综合收益 | -5,298,912.79 | -3,070,301.78 | -761,529.52 | -6,036,786.86 |
| 盈余公积 | 29,310,000 | 29,310,000 | 29,310,000 | 29,310,000 |
| 未分配利润 | 2,201,896,416.88 | 2,203,454,102.09 | 2,182,331,857.9 | 2,226,561,974.59 |
| 归属于母公司股东权益合计 | 2,943,663,294.86 | 2,947,449,591.08 | 2,928,636,119.15 | 2,967,590,978.5 |
| 股东权益合计 | 2,943,663,294.86 | 2,947,449,591.08 | 2,928,636,119.15 | 2,967,590,978.5 |
| 负债和股东权益合计 | 3,721,291,322.67 | 3,664,206,137.97 | 3,554,351,041.68 | 3,648,632,700.16 |
| 公告日期 | 2026-08-28 | 2026-04-30 | 2026-04-23 | 2025-10-25 |
| 审计意见(境内) | | | 标准无保留意见 | |